1205P Treatment sequencing and duration of subsequent tyrosine kinase inhibitors in ALK+ non-small cell lung cancer patients treated with brigatinib in the US
Autor: | K. Sun, C.B. McGuiness, M.O. Jahanzeb, Pingkuan Zhang, M. Gorritz, D.R. Camidge, C-C. Chen, Y. Wu, H. Lin |
---|---|
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Annals of Oncology. 32:S960-S961 |
ISSN: | 0923-7534 |
DOI: | 10.1016/j.annonc.2021.08.1810 |
Databáze: | OpenAIRE |
Externí odkaz: |